MERIT40 controls BRCA1–Rap80 complex integrity and recruitment to DNA double-strand breaks

  1. Genze Shao1,4,
  2. Jeffrey Patterson-Fortin1,2,4,
  3. Troy E. Messick1,
  4. Dan Feng1,
  5. Niraj Shanbhag1,
  6. Yingqun Wang1 and
  7. Roger A. Greenberg1,3,5
  1. 1Department of Cancer Biology, Abramson Family Cancer Research Institute, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA;
  2. 2School of Veterinary Medicine, University of Pennsylvania, Philadelphia, Pennsylvania 19104, USA;
  3. 3Department of Pathology, Abramson Family Cancer Research Institute, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
    1. 4 These authors contributed equally to this work.

    Abstract

    Rap80 targets the breast cancer suppressor protein BRCA1 along with Abraxas and the BRCC36 deubiquitinating enzyme (DUB) to polyubiquitin structures at DNA double-strand breaks (DSBs). These DSB targeting events are essential for BRCA1-dependent DNA damage response-induced checkpoint and repair functions. Here, we identify MERIT40 (Mediator of Rap80 Interactions and Targeting 40 kD)/(C19orf62) as a Rap80-associated protein that is essential for BRCA1–Rap80 complex protein interactions, stability, and DSB targeting. Moreover, MERIT40 is required for Rap80-associated lysine63–ubiquitin DUB activity, a critical component of BRCA1–Rap80 G2 checkpoint and viability responses to ionizing radiation. Thus, MERIT40 represents a novel factor that links BRCA1–Rap80 complex integrity, DSB recognition, and ubiquitin chain hydrolytic activities to the DNA damage response. These findings provide new molecular insights into how BRCA1 associates with independently assembled core protein complexes to maintain genome integrity.

    Keywords

    Footnotes

    • 5 Corresponding author.

      E-MAIL rogergr{at}mail.med.upenn.edu; FAX: (215) 573-2486.

    • Article published online ahead of print. Article and publication date are online at http://www.genesdev.org/cgi/doi/10.1101/gad.1739609.

    • Supplemental material is available at http://www.genesdev.org.

      • Received September 11, 2008.
      • Accepted January 15, 2009.
    | Table of Contents

    Life Science Alliance